[HTML][HTML] Malignant phyllodes tumor of the breast: a systematic review
G Lissidini, A Mulè, A Santoro, G Papa, L Nicosia… - Pathologica, 2022 - ncbi.nlm.nih.gov
Phyllodes tumors (PT) are fibroepithelial neoplasms of the breast showing a peculiar leaf-
like appearance. They account for 0.3 to 1% of all primary breast tumors and 2.5% of all …
like appearance. They account for 0.3 to 1% of all primary breast tumors and 2.5% of all …
[HTML][HTML] Fibroepithelial lesions revisited: implications for diagnosis and management
PH Tan - Modern Pathology, 2021 - Elsevier
Fibroepithelial lesions of the breast, comprising the fibroadenoma and phyllodes tumour, are
a unique group of neoplasms that share histological characteristics but possess different …
a unique group of neoplasms that share histological characteristics but possess different …
Survey of recurrent diagnostic challenges in breast phyllodes tumours
Background Breast phyllodes tumours (PTs) are graded as benign, borderline, or malignant
by analysis of multiple histological features. PT grading is often inconsistent, likely due to …
by analysis of multiple histological features. PT grading is often inconsistent, likely due to …
Fibroepithelial tumours of the breast—a review
MF Lerwill, AHS Lee, PH Tan - Virchows Archiv, 2022 - Springer
Fibroepithelial tumours of the breast are biphasic neoplasms composed of both epithelial
and stromal elements, including the common fibroadenoma and the infrequent phyllodes …
and stromal elements, including the common fibroadenoma and the infrequent phyllodes …
[HTML][HTML] Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing
Breast fibroepithelial lesions are biphasic tumors which comprise the common benign
fibroadenomas (FAs) and the rarer phyllodes tumors (PTs). This study analyzed 262 (42%) …
fibroadenomas (FAs) and the rarer phyllodes tumors (PTs). This study analyzed 262 (42%) …
MED12, TERT and RARA in fibroepithelial tumours of the breast
Fibroepithelial tumours are biphasic neoplasms of the breast comprising the common
benign fibroadenomas and the less common phyllodes tumours (PTs), which have recurrent …
benign fibroadenomas and the less common phyllodes tumours (PTs), which have recurrent …
Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis
JY Tsang, Y Shao, IK Poon, YB Ni, JS Kwan, C Chow… - Pathology, 2022 - Elsevier
Phyllodes tumour (PT) of breast is a rare biphasic neoplasm. Recent next generation
sequencing analyses had revealed novel genetic alterations in PT but lacked a further …
sequencing analyses had revealed novel genetic alterations in PT but lacked a further …
[HTML][HTML] Morphologic and genetic heterogeneity in breast fibroepithelial lesions—a comprehensive mapping study
Breast fibroepithelial lesions (FELs) encompass the common fibroadenoma (FA) and
relatively rare phyllodes tumour (PT); the latter entity is usually classified as benign …
relatively rare phyllodes tumour (PT); the latter entity is usually classified as benign …
Malignant phyllodes tumor of the breast: a practice review
ÂBS Fede, R Pereira Souza, M Doi, M De Brot… - Clinics and …, 2021 - mdpi.com
Introduction: Phyllodes tumor (PT) of the breast, particularly malignant phyllodes tumor
(mPT), is a rare fibroepithelial neoplasm. A complex diagnosis is based on pathologic …
(mPT), is a rare fibroepithelial neoplasm. A complex diagnosis is based on pathologic …
SETD2 alterations and histone H3K36 trimethylation in phyllodes tumor of breast
JY Tsang, ST Lai, YB Ni, Y Shao, IK Poon… - Breast Cancer Research …, 2021 - Springer
Purpose SETD2 is one of the key epigenetic regulatory genes involved in histone
modifications. Its alterations were potentially oncogenic and commonly found in cancers …
modifications. Its alterations were potentially oncogenic and commonly found in cancers …